- Home
- VNDA vs MTLS Comparison
VNDA vs MTLS Comparison
Compare VNDA & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- MTLS
- Stock Information
- Founded
- VNDA 2002
- MTLS 1990
- Country
- VNDA United States
- MTLS Belgium
- Employees
- VNDA N/A
- MTLS N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- MTLS Computer Software: Prepackaged Software
- Sector
- VNDA Health Care
- MTLS Technology
- Exchange
- VNDA Nasdaq
- MTLS Nasdaq
- Market Cap
- VNDA 261.7M
- MTLS 316.0M
- IPO Year
- VNDA 2006
- MTLS 2014
- Fundamental
- Price
- VNDA $4.78
- MTLS $5.95
- Analyst Decision
- VNDA Strong Buy
- MTLS
- Analyst Count
- VNDA 3
- MTLS 0
- Target Price
- VNDA $15.33
- MTLS N/A
- AVG Volume (30 Days)
- VNDA 408.4K
- MTLS 75.7K
- Earning Date
- VNDA 07-30-2025
- MTLS 07-24-2025
- Dividend Yield
- VNDA N/A
- MTLS N/A
- EPS Growth
- VNDA N/A
- MTLS 43.31
- EPS
- VNDA N/A
- MTLS 0.17
- Revenue
- VNDA $201,351,000.00
- MTLS $291,295,936.00
- Revenue This Year
- VNDA $16.86
- MTLS $6.42
- Revenue Next Year
- VNDA $39.78
- MTLS $8.33
- P/E Ratio
- VNDA N/A
- MTLS $35.21
- Revenue Growth
- VNDA 13.37
- MTLS 6.16
- 52 Week Low
- VNDA $3.81
- MTLS $3.93
- 52 Week High
- VNDA $6.37
- MTLS $9.69
- Technical
- Relative Strength Index (RSI)
- VNDA 53.88
- MTLS 56.27
- Support Level
- VNDA $4.85
- MTLS $5.54
- Resistance Level
- VNDA $5.12
- MTLS $5.84
- Average True Range (ATR)
- VNDA 0.18
- MTLS 0.17
- MACD
- VNDA 0.01
- MTLS 0.01
- Stochastic Oscillator
- VNDA 54.05
- MTLS 79.32
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.